Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
The Mosaic Company
MOS
$7.76B
| $69.2M | 0.13% |
1,477,842
+1,412,315
| +2,155% | +$64.1M |
|
|
HME
177
DELISTED
HOME PROPERTIES, INC
HME
| $68.8M | 0.13% |
+942,466
| New | +$68.4M |
|
178
MGM Resorts International
MGM
$11B
| $68.2M | 0.13% |
3,739,545
+2,510,852
| +204% | +$51M |
|
179
XPO
XPO
$23.2B
| $67.7M | 0.13% |
4,333,341
+1,487,056
| +52% | +$24.1M |
|
180
Intercontinental Exchange
ICE
$90.5B
| $67.6M | 0.13% |
1,512,090
+1,000,805
| +196% | +$46.4M |
|
|
INXN
181
DELISTED
Interxion Holding N.V.
INXN
| $67.3M | 0.13% |
2,433,498
+1,746,731
| +254% | +$51.8M |
|
182
UnitedHealth
UNH
$350B
| $66.7M | 0.13% |
546,470
+260,607
| +91% | +$30.8M |
|
183
Community Health Systems
CYH
$424M
| $66.6M | 0.13% |
1,280,665
+556,423
| +77% | +$25M |
|
|
XEC
184
DELISTED
CIMAREX ENERGY CO
XEC
| $66.6M | 0.13% |
+603,762
| New | +$72.1M |
|
|
ETP
185
DELISTED
Energy Transfer Partners L.p.
ETP
| $66.4M | 0.13% |
1,271,212
+1,022,664
| +411% | +$57.1M |
|
186
Nabors Industries
NBR
$1.37B
| $66.3M | 0.13% |
91,860
-30,045
| -25% | -$22.7M |
|
187
Extra Space Storage
EXR
$31B
| $66.2M | 0.13% |
1,015,173
+341,859
| +51% | +$23.2M |
|
188
Agilent Technologies
A
$44.9B
| $65.9M | 0.12% |
1,707,149
+278,677
| +20% | +$11.6M |
|
189
Fidelity National Information Services
FIS
$21.3B
| $65.6M | 0.12% |
1,061,884
+515,833
| +94% | +$33M |
|
|
XL
190
DELISTED
XL Group Ltd.
XL
| $65.4M | 0.12% |
1,759,228
+115,352
| +7% | +$4.32M |
|
191
Philip Morris
PM
$293B
| $65.3M | 0.12% |
814,904
-72,758
| -8% | -$5.99M |
|
192
AT&T
T
$173B
| $65.2M | 0.12% |
2,429,737
+2,406,541
| +10,375% | +$62.2M |
|
193
Starwood Property Trust
STWD
$6.06B
| $65.1M | 0.12% |
3,019,930
+2,979,187
| +7,312% | +$70.6M |
|
194
Unum
UNM
$13.9B
| $64.9M | 0.12% |
1,814,555
-769,167
| -30% | -$26.9M |
|
195
CSX Corp
CSX
$95.6B
| $64.5M | 0.12% |
5,923,821
+4,652,409
| +366% | +$53.9M |
|
196
Equity Lifestyle Properties
ELS
$12.7B
| $64.4M | 0.12% |
2,449,236
+107,320
| +5% | +$2.88M |
|
197
Archrock
AROC
$5.58B
| $63.9M | 0.12% |
1,956,211
-1,075,250
| -35% | -$36.3M |
|
|
MRC
198
DELISTED
MRC Global
MRC
| $63.9M | 0.12% |
4,136,627
+3,845,482
| +1,321% | +$58M |
|
199
AES
AES
$10.5B
| $63.3M | 0.12% |
4,773,308
+1,822,590
| +62% | +$24.5M |
|
200
Thermo Fisher Scientific
TMO
$233B
| $63.1M | 0.12% |
486,614
+142,715
| +41% | +$18.6M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.